Drugs / FURESTEM-OA Inj.
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05944627 | Jul 2023 → Mar 2024 | osteoarthritis, knee | Kang Stem Biotech Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FURESTEM-OA Inj. | “FURESTEM-OA Kit Inj. is a combination medical product in which FURESTEM-OA Inj. (solution 1) is the primary mode of action and CAM Inj. (solution 2) acts as an auxiliary.” NCT05944627 ↗ |
| Route | Other | “Subjects are slowly administered FURESTEM-OA Kit Inj. once into the knee joint cavity” NCT05944627 ↗ |